Amyloidosis trials in Cyprus

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Where

  Agios Dometios

  Age

  18 years to 85 years

  People

  125 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07223203 · EU 2025-522544-40-00